deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT03973697

Penn Microbiome Therapy for Recurrent Clostridium Difficile Infection

A Phase II, Randomized Trial to Evaluate the Optimal Dosing of Fecal Microbiota Transplantation Using the Penn Microbiome Therapy Products for Recurrent Clostridium Difficile Infection

Sponsor: University of Pennsylvania

Conditions Recurrent Clostridium Difficile Infection
Interventions Penn Microbiome Therapy - 001 Penn Microbiome Therapy - 002 Penn Microbiome Therapy - 003
Updated 18 times since 2019 Last updated: Oct 6, 2023 Started: Jan 13, 2020 Primary completion: Aug 11, 2021 Completion: Dec 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Administrative reasons

Other terminated trials from University of Pennsylvania

See all terminations from University of Pennsylvania

Listed as NCT03973697, this PHASE2 trial focuses on Recurrent Clostridium Difficile Infection and remains terminated or withdrawn. Sponsored by University of Pennsylvania, it has been updated 18 times since 2020, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Nov 2019 · 2 months · monthly snapshot~Nov 2019 – ~Jan 2020 · 2 months · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Apr 2020 · 2 months · monthly snapshot~Apr 2020 – ~Oct 2020 · 6 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Feb 2022 · 2 months · monthly snapshot~Feb 2022 – ~Apr 2022 · 59 days · monthly snapshot~Apr 2022 – ~Jul 2022 · 3 months · monthly snapshot~Jul 2022 – ~Dec 2023 · 17 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

18 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Dec 2023 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jul 2022 — Dec 2023 [monthly]

    Terminated PHASE2

  5. Apr 2022 — Jul 2022 [monthly]

    Terminated PHASE2

    Status: Active Not Recruiting → Terminated

▶ Show 13 earlier versions

  1. Feb 2022 — Apr 2022 [monthly]

    Active Not Recruiting PHASE2

  2. Dec 2021 — Feb 2022 [monthly]

    Active Not Recruiting PHASE2

  3. Oct 2021 — Dec 2021 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  4. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

  5. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE2

    Status: Active Not Recruiting → Recruiting

  6. Oct 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

  7. Apr 2020 — Oct 2020 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  8. Feb 2020 — Apr 2020 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  9. Jan 2020 — Feb 2020 [monthly]

    Not Yet Recruiting PHASE2

  10. Nov 2019 — Jan 2020 [monthly]

    Not Yet Recruiting PHASE2

  11. Sep 2019 — Nov 2019 [monthly]

    Not Yet Recruiting PHASE2

  12. Aug 2019 — Sep 2019 [monthly]

    Not Yet Recruiting PHASE2

  13. Jul 2019 — Aug 2019 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Pennsylvania
Data source: University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations